Coherus Oncology Inc (CHRS)

Other Income/Expenses (Net)

-$4.55M

TTM · Period ending: · USD

CHRS logo

CHRS Other Income/Expenses (Net)

Latest reported-$4.55M
CHRS Other Income/Expenses (Net) ($5.50M → -$4.55M)
High-resolution chart · PNG

CHRS other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-3,590,000
140,174,000
-35,073,000
-34,874,000
-23,242,000
-20,612,000
-14,993,000
-4,993,000
-6,150,000
-11,857,000
-4,871,000
-22,495,000
-17,642,000
5,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.